Os genes ERCC1 e RRM1 no carcinoma broncopulmonar ERCC1 and RRM1 genes in lung cancer

Os genes ERCC1 e RRM1 no carcinoma broncopulmonar ERCC1 and RRM1 genes in lung cancer

No cancro do pulmão, ainda não se obteve sobrevivência expressiva dos doentes que se apresentam em estádios não cirúrgicos. Os doentes com carcinoma de não pequenas células são tratados com platina e outros fármacos, para os quais se podem caracterizar actualmente marcadores preditivos de resposta t...

Full description

Bibliographic Details
Main Authors:	Lina Carvalho, António Silva, Cláudia Andrade, Cláudia Barroso, Cláudia Farinha, José Carlos Fernandes, Raquel Landeiro
Format:	Article
Language:	English
Published:	Elsevier 2009-08-01
Series:	Revista Portuguesa de Pneumologia
Subjects:	Carcinoma do pulmão de células não pequenas RRM1 ERCC1 Non-small cell lung cancer
Online Access:	http://www.scielo.oces.mctes.pt/scielo.php?script=sci_arttext&pid=S0873-21592009000400008

Similar Items

RRM1 and ERCC1 as biomarkers in patients with locally advanced and metastatic malignant pleural mesothelioma treated with continuous infusion of low-dose gemcitabine plus cisplatin
by: Wendy Muñoz-Montaño, et al.
Published: (2021-08-01)

Association between TOP2A, RRM1, HER2, ERCC1 expression and response to chemotherapy in patients with non-muscle invasive bladder cancer
by: Zhifei Liu, et al.
Published: (2022-06-01)

Real-Time PCR Data Processing Shown by the Analysis of Colorectal Specific Candidate Genes, ERCC1, RRM1 and TS in Relation to β2M as Endogenous Control
by: Melanie Demes, et al.
Published: (2012-02-01)

Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy
by: Leng Xue-Feng, et al.
Published: (2012-03-01)

Prognostic Analysis of ERCC1, RRM1 and p53 Expressions in Postoperative Stage Ⅰ-Ⅱ Lung Cancer
by: Baohui HAN, et al.
Published: (2009-05-01)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
by: Hadeel Obiedat, et al.
Published: (2018-07-01)

Os genes ERCC1 e RRM1 no carcinoma broncopulmonar
by: Lina Carvalho, et al.
Published: (2009-07-01)

Genetic polymorphisms in ERCC1 and ERCC2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis
by: Haiguang Zhang, et al.
Published: (2017-04-01)

Involvement of ERCC1 (rs3212986) and ERCC2 (rs1799793, rs13181) polymorphisms of DNA repair genes in breast cancer occurrence in Burkina Faso
by: Marc Donald Wilfried Adico, et al.
Published: (2023-04-01)

Genetic polymorphisms and haplotypes of ERCC1 and ERCC2 associated with quality of life, depression, and anxiety status among patients with lung cancer
by: Yunxiang Tang, et al.
Published: (2021-07-01)

The ZEB2‐dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancer
by: Rahul Sreekumar, et al.
Published: (2021-08-01)

ERCC1 polymorphism and its expression associated with ischemic stroke in Chinese population
by: Xiao-Dong Deng, et al.
Published: (2023-01-01)

Increased ERCC1 expression is linked to chromosomal aberrations and adverse tumor biology in prostate cancer
by: Frank Jacobsen, et al.
Published: (2017-07-01)

ERCC1 Is a Predictor of Anthracycline Resistance and Taxane Sensitivity in Early Stage or Locally Advanced Breast Cancers
by: Tarek M. A. Abdel-Fatah, et al.
Published: (2019-08-01)

XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer
by: Ming-Yii Huang, et al.
Published: (2023-05-01)

Clinical Perspectives of ERCC1 in Bladder Cancer
by: Konstantinos Koutsoukos, et al.
Published: (2020-11-01)

Association Between ERCC1 rs3212986 and ERCC2/XPD rs1799793 and OS in Patients With Advanced Esophageal Cancer
by: Elisa Boldrin, et al.
Published: (2019-02-01)

Perspectives of ERCC1 in early-stage and advanced cervical cancer: From experiments to clinical applications
by: Pei Du, et al.
Published: (2023-01-01)

Associations of individual and joint expressions of ERCC6 and ERCC8 with clinicopathological parameters and prognosis of gastric cancer
by: Jing Chen, et al.
Published: (2021-07-01)

Role of ERCC1 expression in colorectal adenoma-carcinoma sequence and relation to other mismatch repair proteins expression, clinicopathological features and prognosis in mucinous and non-mucinous colorectal carcinoma
by: Abd AlRahman Mohammad Foda, et al.
Published: (2019-01-01)

Association between Polymorphisms of ERCC1 and Response in Patients with Advanced Non-small Cell Lung Cancer Receiving Cisplatin-based Chemotherapy
by: Yanfei GU, et al.
Published: (2010-04-01)

Predictive value of KRAS mutation and excision repair cross-complementing 1 (ERCC1) protein overexpression in patients with colorectal cancer administered FOLFOX regimen
by: Sun Min Park, et al.
Published: (2021-05-01)

Initiation phase cellular reprogramming ameliorates DNA damage in the ERCC1 mouse model of premature aging
by: Patrick Treat Paine, et al.
Published: (2024-01-01)

Gene-environment and gene-gene interactions between CHRNA3 rs1051730, XRCC1 rs25487, and ERCC1 rs735482 variants highly elevate the risk of lung cancer
by: Nada Ezzeldin, et al.
Published: (2019-11-01)

The XPF-ERCC1 Complex Is Essential for Genome Stability and Is Involved in the Mechanism of Gene Targeting in Physcomitrella patens
by: Anouchka Guyon-Debast, et al.
Published: (2019-05-01)

High Expression of RRM1 Mediated by ncRNAs Correlates with Poor Prognosis and Tumor Immune Infiltration of Hepatocellular Carcinoma
by: Mao G, et al.
Published: (2022-03-01)

Knockdown of lncRNA KCNQ1OT1 inhibits glioma progression by regulating miR-338-3p/RRM2
by: Yin Zhangxing, et al.
Published: (2020-03-01)

RRM2 Mediates the Anti-Tumor Effect of the Natural Product Pectolinarigenin on Glioblastoma Through Promoting CDK1 Protein Degradation by Increasing Autophagic Flux
by: Haiping Jiang, et al.
Published: (2022-05-01)

ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis
by: Yuqiang Zhang, et al.
Published: (2021-06-01)

Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
by: Ning Tang, et al.
Published: (2017-06-01)

Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study
by: Marina Piljić Burazer, et al.
Published: (2019-09-01)

Relations between RRM1 Protein Expression Levels and Effects of Gemcitabine and Cisplatin Chemotherapy in Advanced Non-small Cell Lung Cancer Patients
by: Zhiqiang GAO, et al.
Published: (2011-04-01)

Tissue-Specific DNA Repair Activity of ERCC-1/XPF-1
by: Mariangela Sabatella, et al.
Published: (2021-01-01)

RRM2 Regulates Sensitivity to Sunitinib and PD‐1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway
by: Wei Xiong, et al.
Published: (2021-09-01)

ERCC1 19007 Polymorphism in Greek Patients with Advanced Urothelial Cancer Treated with Platinum-Based Chemotherapy: Effect of the Changing Treatment Paradigm: A Cohort Study by the Hellenic GU Cancer Group
by: Aristotelis Bamias, et al.
Published: (2021-11-01)

ERCC1 Overexpression Increases Radioresistance in Colorectal Cancer Cells
by: Yi-Jung Huang, et al.
Published: (2022-09-01)

Function and Interactions of ERCC1-XPF in DNA Damage Response
by: Maryam Faridounnia, et al.
Published: (2018-12-01)

ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia
by: Dhouha Jamai, et al.
Published: (2023-07-01)

Association of DNA repair gene variants with colorectal cancer: risk, toxicity, and survival
by: Hamideh Salimzadeh, et al.
Published: (2020-05-01)

Multi-Faceted Roles of ERCC1-XPF Nuclease in Processing Non-B DNA Structures
by: Tonia T. Li, et al.
Published: (2022-10-01)